<DOC>
	<DOC>NCT00829777</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of intravenous 6β-Naltrexol administered to opiate dependent subjects</brief_summary>
	<brief_title>Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>Opiate dependent males and females age 2145 on stable doses of methadone Fluent English speaker Willing and able to give written consent Pregnancy or lactation FOR MORE DETAILS CONTACT THE RESEARCH CLINIC.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Naloxone</keyword>
	<keyword>6β-Naltrexol</keyword>
	<keyword>Opioid-dependent</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>peripheral effects of withdrawal</keyword>
	<keyword>central effects of withdrawal</keyword>
</DOC>